Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02628405
Title R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications

diffuse large B-cell lymphoma

B-cell lymphoma

Therapies

Carboplatin + Etoposide + Ifosfamide + Lenalidomide + Rituximab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.